氨酰-tRNA合成酶在恶性肿瘤中的 研究进展
Advances in the Study of Aminoacyl-tRNA Synthetases in Malignant Tumors
摘要: 氨酰-tRNA合成酶(aminoacyl-tRNA synthetases,ARSs)是一类在进化上高度保守、广泛表达的必需酶,主要催化特定氨基酸与同源转运RNA(tRNA)的连接,保证蛋白质翻译的准确性。近年来研究表明,部分ARSs除经典氨酰化功能外,还可通过结构域介导的蛋白相互作用、细胞外分泌、氨基酸感应与信号转导等“非经典功能”参与肿瘤增殖、侵袭转移、免疫微环境重塑及治疗反应调控。本文综述了ARSs的分类与非经典功能,并聚焦于肿瘤关键生物学过程的主线,梳理了其在各类恶性肿瘤中的研究进展。在此基础上,进一步总结了ARSs作为肿瘤诊断及预后标志物的潜在价值,分析了靶向ARSs的干预策略,以期为肿瘤机制探索与转化应用提供新思路。
Abstract: Aminoacyl-tRNA synthetases (ARSs) are a family of evolutionarily highly conserved and ubiquitously expressed essential enzymes. Their canonical function is to catalyze the ligation of specific amino acids to their cognate transfer RNAs (tRNAs), thereby ensuring the fidelity of protein translation. However, accumulating evidence in recent years has revealed that beyond this classical aminoacylation function, certain ARSs participate in tumor proliferation, invasion and metastasis, immune microenvironment remodeling, and the modulation of therapeutic responses through “non-canonical functions”. These functions are mediated by mechanisms such as domain-mediated protein-protein interactions, extracellular secretion, amino acid sensing, and signal transduction. This review summarizes the classification and non-canonical functions of ARSs. Focusing on the principal processes of tumor biology, it synthesizes the research progress on ARSs across various malignant tumors. Furthermore, it evaluates the potential value of ARSs as diagnostic and prognostic biomarkers and analyzes intervention strategies targeting ARSs, aiming to provide novel insights for both fundamental cancer research and translational applications.
文章引用:赵冠军, 张毅芳. 氨酰-tRNA合成酶在恶性肿瘤中的 研究进展[J]. 临床医学进展, 2026, 16(4): 521-527. https://doi.org/10.12677/acm.2026.1641276

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Rubio Gomez, M.A. and Ibba, M. (2020) Aminoacyl-tRNA Synthetases. RNA, 26, 910-936. [Google Scholar] [CrossRef] [PubMed]
[3] Turvey, A.K., Horvath, G.A. and Cavalcanti, A.R.O. (2022) Aminoacyl-tRNA Synthetases in Human Health and Disease. Frontiers in Physiology, 13, Article ID: 1029218. [Google Scholar] [CrossRef] [PubMed]
[4] 王耀锋, 宋自芳. 氨酰tRNA合成酶非经典作用的研究进展[J]. 华中科技大学学报(医学版), 2023, 52(4): 564-568.
[5] Rajendran, V., Kalita, P., Shukla, H., Kumar, A. and Tripathi, T. (2018) Aminoacyl-tRNA Synthetases: Structure, Function, and Drug Discovery. International Journal of Biological Macromolecules, 111, 400-414. [Google Scholar] [CrossRef] [PubMed]
[6] Kwon, N.H., Fox, P.L. and Kim, S. (2019) Aminoacyl-tRNA Synthetases as Therapeutic Targets. Nature Reviews Drug Discovery, 18, 629-650. [Google Scholar] [CrossRef] [PubMed]
[7] Mirande, M. (2017) The Aminoacyl-tRNA Synthetase Complex. In: Harris, J.R. and Marles-Wright, J., Eds., Macromolecular Protein Complexes, Springer International Publishing, 505-522. [Google Scholar] [CrossRef] [PubMed]
[8] Havrylenko, S. and Mirande, M. (2015) Aminoacyl-tRNA Synthetase Complexes in Evolution. International Journal of Molecular Sciences, 16, 6571-6594. [Google Scholar] [CrossRef] [PubMed]
[9] Laporte, D., Huot, J.L., Bader, G., Enkler, L., Senger, B. and Becker, H.D. (2014) Exploring the Evolutionary Diversity and Assembly Modes of Multi‐Aminoacyl‐tRNA Synthetase Complexes: Lessons from Unicellular Organisms. FEBS Letters, 588, 4268-4278. [Google Scholar] [CrossRef] [PubMed]
[10] Hyeon, D.Y., Kim, J.H., Ahn, T.J., Cho, Y., Hwang, D. and Kim, S. (2019) Evolution of the Multi-tRNA Synthetase Complex and Its Role in Cancer. Journal of Biological Chemistry, 294, 5340-5351. [Google Scholar] [CrossRef] [PubMed]
[11] Cui, H., Kapur, M., Diedrich, J.K., Yates, J.R., Ackerman, S.L. and Schimmel, P. (2020) Regulation of Ex-Translational Activities Is the Primary Function of the Multi-tRNA Synthetase Complex. Nucleic Acids Research, 49, 3603-3616. [Google Scholar] [CrossRef] [PubMed]
[12] Khan, K., Gogonea, V. and Fox, P.L. (2022) Aminoacyl-tRNA Synthetases of the Multi-tRNA Synthetase Complex and Their Role in Tumorigenesis. Translational Oncology, 19, Article ID: 101392. [Google Scholar] [CrossRef] [PubMed]
[13] Zhou, Z., Sun, B., Nie, A., Yu, D. and Bian, M. (2020) Roles of Aminoacyl-tRNA Synthetases in Cancer. Frontiers in Cell and Developmental Biology, 8, Article ID: 599765. [Google Scholar] [CrossRef] [PubMed]
[14] Sung, Y., Yoon, I., Han, J.M. and Kim, S. (2022) Functional and Pathologic Association of Aminoacyl-tRNA Synthetases with Cancer. Experimental & Molecular Medicine, 54, 553-566. [Google Scholar] [CrossRef] [PubMed]
[15] Guo, M., Yang, X. and Schimmel, P. (2010) New Functions of Aminoacyl-tRNA Synthetases beyond Translation. Nature Reviews Molecular Cell Biology, 11, 668-674. [Google Scholar] [CrossRef] [PubMed]
[16] Park, S.G., Ewalt, K.L. and Kim, S. (2005) Functional Expansion of Aminoacyl-tRNA Synthetases and Their Interacting Factors: New Perspectives on Housekeepers. Trends in Biochemical Sciences, 30, 569-574. [Google Scholar] [CrossRef] [PubMed]
[17] Yao, P. and Fox, P.L. (2013) Aminoacyl‐tRNA Synthetases in Medicine and Disease. EMBO Molecular Medicine, 5, 332-343. [Google Scholar] [CrossRef] [PubMed]
[18] Park, S.G., Schimmel, P. and Kim, S. (2008) Aminoacyl tRNA Synthetases and Their Connections to Disease. Proceedings of the National Academy of Sciences, 105, 11043-11049. [Google Scholar] [CrossRef] [PubMed]
[19] Guo, M., Schimmel, P. and Yang, X. (2009) Functional Expansion of Human tRNA Synthetases Achieved by Structural Inventions. FEBS Letters, 584, 434-442. [Google Scholar] [CrossRef] [PubMed]
[20] Sissler, M., González-Serrano, L.E. and Westhof, E. (2017) Recent Advances in Mitochondrial Aminoacyl-tRNA Synthetases and Disease. Trends in Molecular Medicine, 23, 693-708. [Google Scholar] [CrossRef] [PubMed]
[21] Yakobov, N., Debard, S., Fischer, F., Senger, B. and Becker, H.D. (2018) Cytosolic Aminoacyl-tRNA Synthetases: Unanticipated Relocations for Unexpected Functions. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms, 1861, 387-400. [Google Scholar] [CrossRef] [PubMed]
[22] Jia, J., Arif, A., Ray, P.S. and Fox, P.L. (2008) WHEP Domains Direct Noncanonical Function of Glutamyl-Prolyl tRNA Synthetase in Translational Control of Gene Expression. Molecular Cell, 29, 679-690. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, C., Lin, X., Zhao, Q., Wang, Y., Jiang, F., Ji, C., et al. (2020) YARS as an Oncogenic Protein That Promotes Gastric Cancer Progression through Activating PI3K-Akt Signaling. Journal of Cancer Research and Clinical Oncology, 146, 329-342. [Google Scholar] [CrossRef] [PubMed]
[24] Fang, Z., Wang, X., Yan, Q., Zhang, S. and Li, Y. (2017) Knockdown of IARS2 Suppressed Growth of Gastric Cancer Cells by Regulating the Phosphorylation of Cell Cycle-Related Proteins. Molecular and Cellular Biochemistry, 443, 93-100. [Google Scholar] [CrossRef] [PubMed]
[25] Di, X., Jin, X., Ma, H., Wang, R., Cong, S., Tian, C., et al. (2019) The Oncogene IARS2 Promotes Non-Small Cell Lung Cancer Tumorigenesis by Activating the AKT/MTOR Pathway. Frontiers in Oncology, 9, Article No. 393. [Google Scholar] [CrossRef] [PubMed]
[26] Fang, T., Jiang, J., Yu, W., Li, R. and Tian, H. (2023) DARS2 Promotes the Occurrence of Lung Adenocarcinoma via the ERK/c-Myc Signaling Pathway. Thoracic Cancer, 14, 3511-3521. [Google Scholar] [CrossRef] [PubMed]
[27] Tian, H., Yan, H., Zhang, Y., Fu, Q., Li, C., He, J., et al. (2022) Knockdown of Mitochondrial Threonyl-tRNA Synthetase 2 Inhibits Lung Adenocarcinoma Cell Proliferation and Induces Apoptosis. Bioengineered, 13, 5190-5204. [Google Scholar] [CrossRef] [PubMed]
[28] Liu, B., Katoh, H., Komura, D., Yamamoto, A., Ochi, M., Onoyama, T., et al. (2022) Functional Genomics Screening Identifies Aspartyl‐tRNA Synthetase as a Novel Prognostic Marker and a Therapeutic Target for Gastric Cancers. The Journal of Pathology, 258, 106-120. [Google Scholar] [CrossRef] [PubMed]
[29] Qin, X., Li, C., Guo, T., Chen, J., Wang, H., Wang, Y., et al. (2017) Upregulation of DARS2 by HBV Promotes Hepatocarcinogenesis through the miR-30e-5p/MAPK/NFAT5 Pathway. Journal of Experimental & Clinical Cancer Research, 36, Article No. 148. [Google Scholar] [CrossRef] [PubMed]
[30] Zong, Z., Xie, F., Wang, S., Wu, X., Zhang, Z., Yang, B., et al. (2024) Alanyl-tRNA Synthetase, AARS1, Is a Lactate Sensor and Lactyltransferase That Lactylates P53 and Contributes to Tumorigenesis. Cell, 187, 2375-2392.e33. [Google Scholar] [CrossRef] [PubMed]
[31] Ju, J., Zhang, H., Lin, M., Yan, Z., An, L., Cao, Z., et al. (2024) The Alanyl-tRNA Synthetase AARS1 Moonlights as a Lactyltransferase to Promote YAP Signaling in Gastric Cancer. Journal of Clinical Investigation, 134, e174587. [Google Scholar] [CrossRef] [PubMed]
[32] Kim, S.B., Kim, H.R., Park, M.C., Cho, S., Goughnour, P.C., Han, D., et al. (2017) Caspase-8 Controls the Secretion of Inflammatory Lysyl-tRNA Synthetase in Exosomes from Cancer Cells. Journal of Cell Biology, 216, 2201-2216. [Google Scholar] [CrossRef] [PubMed]
[33] Nam, S.H., Kim, D., Lee, D., Lee, H., Song, D., Jung, J.W., et al. (2018) Lysyl-tRNA Synthetase-Expressing Colon Spheroids Induce M2 Macrophage Polarization to Promote Metastasis. Journal of Clinical Investigation, 128, 5034-5055. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, Z., Lu, Z., Lin, S., Xia, J., Zhong, Z., Xie, Z., et al. (2022) Leucine-tRNA-Synthetase-2-Expressing B Cells Contribute to Colorectal Cancer Immunoevasion. Immunity, 55, 1067-1081.e8. [Google Scholar] [CrossRef] [PubMed]
[35] Yang, H., Ma, L., Deng, W., Fu, B., Nie, J. and Liu, X. (2024) Prognostic Biomarker DARS2 Correlated with Immune Infiltrates in Bladder Tumor. Frontiers in Immunology, 14, Article ID: 1301945. [Google Scholar] [CrossRef] [PubMed]
[36] Liu, H., Fredimoses, M., Niu, P., Liu, T., Qiao, Y., Tian, X., et al. (2021) EPRS/GLURS Promotes Gastric Cancer Development via WNT/GSK-3β/β-Catenin Signaling Pathway. Gastric Cancer, 24, 1021-1036. [Google Scholar] [CrossRef] [PubMed]
[37] Wellman, T.L., Eckenstein, M., Wong, C., Rincon, M., Ashikaga, T., Mount, S.L., et al. (2014) Threonyl-tRNA Synthetase Overexpression Correlates with Angiogenic Markers and Progression of Human Ovarian Cancer. BMC Cancer, 14, Article No. 620. [Google Scholar] [CrossRef] [PubMed]
[38] Fang, Q., Lin, J., Gao, L., Pan, R. and Zheng, X. (2022) Targeting Mitochondrial Tyrosyl-tRNA Synthetase YARS2 Suppresses Colorectal Cancer Progression. Cancer Biology & Therapy, 23, 1-8. [Google Scholar] [CrossRef] [PubMed]
[39] Lee, K., Lee, H., Han, D., Moon, W.K., Kim, K., Oh, H.J., et al. (2020) Combined the SMAC Mimetic and BCL2 Inhibitor Sensitizes Neoadjuvant Chemotherapy by Targeting Necrosome Complexes in Tyrosine Aminoacyl-tRNA Synthase-Positive Breast Cancer. Breast Cancer Research, 22, Article No. 130. [Google Scholar] [CrossRef] [PubMed]
[40] Zhao, J., Bai, H., Li, X., Yan, J., Zou, G., Wang, L., et al. (2021) Glucose-Sensitive Acetylation of Seryl tRNA Synthetase Regulates Lipid Synthesis in Breast Cancer. Signal Transduction and Targeted Therapy, 6, Article No. 303. [Google Scholar] [CrossRef] [PubMed]
[41] Passarelli, M.C., Pinzaru, A.M., Asgharian, H., Liberti, M.V., Heissel, S., Molina, H., et al. (2022) Leucyl-tRNA Synthetase Is a Tumour Suppressor in Breast Cancer and Regulates Codon-Dependent Translation Dynamics. Nature Cell Biology, 24, 307-315. [Google Scholar] [CrossRef] [PubMed]
[42] Zin, I., China, A., Khan, K., Nag, J.K., Vasu, K., Deshpande, G.M., et al. (2024) Akt-Dependent Nuclear Localization of EPRS1 Activates PARP1 in Breast Cancer Cells. Proceedings of the National Academy of Sciences, 121, e2303642121. [Google Scholar] [CrossRef] [PubMed]
[43] Kim, B., Jung, W.Y., Lee, H., Kang, Y., Jang, Y., Hong, S.W., et al. (2014) Lysyl-tRNA Synthetase (KRS) Expression in Gastric Carcinoma and Tumor-Associated Inflammation. Annals of Surgical Oncology, 21, 2020-2027. [Google Scholar] [CrossRef] [PubMed]
[44] Kim, E.Y., Lee, J.G., Lee, J.M., Kim, A., Yoo, H.C., Kim, K., et al. (2019) Therapeutic Effects of the Novel Leucyl-tRNA Synthetase Inhibitor BC-LI-0186 in Non-Small Cell Lung Cancer. Therapeutic Advances in Medical Oncology, 11. [Google Scholar] [CrossRef] [PubMed]
[45] Yoon, I., Kim, U., Choi, J. and Kim, S. (2024) Disease Association and Therapeutic Routes of Aminoacyl-tRNA Synthetases. Trends in Molecular Medicine, 30, 89-105. [Google Scholar] [CrossRef] [PubMed]
[46] Park, M.C., Kang, T., Jin, D., Han, J.M., Kim, S.B., Park, Y.J., et al. (2012) Secreted Human Glycyl-tRNA Synthetase Implicated in Defense against ERK-Activated Tumorigenesis. Proceedings of the National Academy of Sciences, 109, E640-E647. [Google Scholar] [CrossRef] [PubMed]
[47] Fosgerau, K. and Hoffmann, T. (2015) Peptide Therapeutics: Current Status and Future Directions. Drug Discovery Today, 20, 122-128. [Google Scholar] [CrossRef] [PubMed]
[48] Gupta, S., Jani, J., Vijayasurya, Mochi, J., Tabasum, S., Sabarwal, A., et al. (2023) Aminoacyl‐tRNA Synthetase—A Molecular Multitasker. The FASEB Journal, 37, e23219. [Google Scholar] [CrossRef] [PubMed]